OUSM
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM tracks an index of US small-cap stocks weighted for exposure to quality, low volatility, and high yield factors.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 871.3 M
ASSETS UNDER MGMT
48 bp
EXPENSES
Fund Basics
| Inception date | Dec 30, 2016 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Monthly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CHEMED CORP | 2.4 % |
| TEXAS ROADHOUSE INC | 2.3 % |
| SEI INVESTMENTS COMPANY | 2.2 % |
| NATIONAL HEALTHCARE CORP | 2.2 % |
| PRIMERICA INC | 2.2 % |
| RADIAN GROUP INC | 2.2 % |
| MGIC INVESTMENT CORP | 2.2 % |
| ESSENT GROUP LTD | 2.1 % |
| DONALDSON CO INC | 2.1 % |
| ROYALTY PHARMA PLC CLASS A | 2.0 % |
Constituent Breakdown
| Number of holdings | 105 |
| Herfindahl-Hirschman Index | 146 |
| Wgt avg mkt cap (mns) | $8,130 |
| Large cap (>$10bn) | 31.5% |
| Mid cap ($2-10bn) | 65.0% |
| Small cap (<$2bn) | 1.3% |
| Developed mkts. | 97.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.7 % |
 |
BERMUDA | 2.2 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 11.2% | 12.0% | 5.0% | 9.3% | 6.3% | -- | -- | 7.2% |
| Dividend Yield | 1.1% | 2.4% | 2.1% | 2.1% | 2.0% | -- | -- | 2.2% |
| Total Returns | 12.4% | 14.3% | 7.1% | 11.4% | 8.3% | -- | -- | 9.4% | Ann. Volatility | 13.4% | 13.2% | 15.7% | 15.0% | 16.3% | -- | -- | 18.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.58 | 32% |
| MSCI EAFE | 0.47 | 32% |
| MSCI Emg Mkts | 0.20 | 14% |
Liquidity Measures
| Avg. volume (000) | 76 |
| ADV traded (mns) | $4 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.14% |
Technical Indicators
| 30d moving avg. (EMA) | $47.86 |
| Relative strength (RSI) | 59 |
| MACD/Signal | 0.49/0.44 |
| Bollinger Bands (Upper/Lower) | $49.42/$46.67 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. OUSM |
Expenses vs. OUSM |
ALTAR Score™ vs. OUSM |
|---|---|---|---|---|
| RNMC | First Trust Mid Cap US Equity Select ETF | 22.1% | +12 bp | -0.7% |
| SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | 21.7% | +12 bp | -1.9% |
| HSMV | First Trust Horizon Managed Volatility Small/Mid ETF | 21.6% | +32 bp | -1.2% |
| REGL | ProShares S&P MidCap 400 Dividend Aristocrats ETF | 19.3% | -8 bp | -1.4% |
| FSCS | First Trust SMID Capital Strength ETF | 19.0% | +12 bp | -0.6% |
| SMMV | iShares MSCI USA Small-Cap Min Vol Factor ETF | 18.8% | -28 bp | -2.1% |
| MCOW | Pacer S&P MidCap 400 Quality FCF Aristocrats ETF | 18.7% | +1 bp | -1.1% |
| XMLV | Invesco S&P MidCap Low Volatility ETF | 18.4% | -23 bp | -1.3% |
| OSCV | Opus Small Cap Value ETF | 17.7% | +31 bp | -2.2% |
| DON | WisdomTree U.S. MidCap Dividend Fund | 17.3% | -10 bp | -0.1% |
Risk and Returns: OUSM vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/4/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
8.3%
ALTAR SCORE™
94th
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.0%. OUSM's ALTAR Score™ is approximately 1.6 standard
deviations above the category average. This places OUSM in the 94th percentile
among funds in the category.
Sell-Side Consensus
$53.54
PRICE TARGET
+8.9%
UPSIDE